New drug trial to investigate treatment for patients with bronchiectasis
200,000 people in the UK have what is considered a ‘hidden’ lung condition
Read More
Tag: European Research Network for bronchiectasis
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
